Search by therapeutic area for drugs approved by the Food and Drug Administration (FDA) for sale in the
United States. Click on an area below to view the complete list of drugs in that category or
review descriptions for our therapeutic
area list to assist you in your search.
FDA Approved Drugs for Psychiatry/Psychology
Drugs Approved in 2012
Qsymia (phentermine + topiramate extended-release); Vivus;
For the treatment of chronic weight management, Approved July 2012
Quillivant XR (methylphenidate hydrochloride); NextWave Pharmaceuticals;
For the treatment of Attention Deficit Hyperactivity Disorder, Approved September 2012
Drugs Approved in 2011
Intermezzo (zolpidem tartrate sublingual tablet); Transcept Pharmaceuticals;
For the treatment of insomnia, Approved November 2011
Viibryd (vilazodone hydrochloride); Clinical Data;
For the treatment of major depressive disorder, Approved January 2011
Drugs Approved in 2010
Latuda (lurasidone); Sunovion;
For the treatment of schizophrenia, Approved October 2010
Oleptro (trazodone hydrochloride); Labopharm;
For the treatment of major depressive disorder, Approved February 2010
Vivitrol (naltrexone for extended-release injectable suspension); Alkermes;
For the prevention of relapse to opioid dependence, Approved October 2010
Drugs Approved in 2009
Edluar (zolpidem tartrate); Orexo;
For the treatment of insomnia, Approved March 2009
Fanapt (iloperidone); Vanda;
For the treatment of schizophrenia, Approved May of 2009
Intuniv (guanfacine extended-release); Shire Pharmaceuticals;
For the treatment of ADHD in children and adolescents, Approved September 2009
Saphris (asenapine); Schering-Plough;
For the treatment of schizophrenia and manic or mixed bipolar 1 episodes, Approved August of 2009
Drugs Approved in 2008
Aplenzin (bupropion hydrobromide); Biovail Laboratories;
For the treatment of major depressive disorder, Approved April 2008
Stavzor (valproic acid delayed release); Banner Pharmacaps;
For the treatment of bipolar manic disorder, seizures and migraine headaches, Approved July 2008
Drugs Approved in 2007
Vyvanse (Lisdexamfetamine Dimesylate); New River;
For the treatment of Attention-Deficit/Hyperactivity Disorder, Approved February 2007
Drugs Approved in 2006
Chantix (varenicline); Pfizer;
For the treatment of nicotine addiction, Approved May 2006
Invega (paliperidone); Janssen Pharmaceuticals;
For the treatment of schizophrenia, Approved December 2006
Vivitrol (naltrexone for extended-release injectable suspension); Alkermes;
For the treatment of alcohol dependence, Approved April 2006
Drugs Approved in 2004
Cymbalta (duloxetine); Eli Lilly;
For the treatment of major depressive disorder, Approved August 2004
Drugs Approved in 2002
Abilify (aripiprazole); Bristol-Myers Squibb, Otsuka America Pharmaceutical;
Oral drug for the treatment of schizophrenia, Approved November 2002
Geodon (ziprasidone mesylate); Pfizer;
To control agitated behavior and psychotic symptoms in schizophrenia patients, Approved June 2002
Lexapro (escitalopram oxalate); Forest Laboratories;
An orally administered selective serotonin reuptake inhibitor useful for the treatment for major depressive disorder, Approved August 2002
Paxil CR (paroxetine hydrochloride); GlaxoSmithKline;
Oral tablet for the treatment of depression and panic disorder, Approved February 2002
Ritalin LA (methylphenidate HCl); Novartis;
Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD), Approved June 2002
Strattera (atomoxetine HCl); Eli Lilly;
For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents and adults., December 2002
Subutex/Suboxone (buprenorphine/naloxone); Reckitt Benckiser;
Oral tablets for the treatment of opiate dependence, Approved October 2002
Zoloft (sertraline HCl); Pfizer;
Oral tablets for the treatment of premenstrual dysphoric mood disorder (PMDD), Approved May 2002
Drugs Approved in 2001
Adderall XR; Shire Pharmaceuticals;
Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD), Approved October 2001
Focalin (dexmethylphenidate HCl); Celgene;
For the treatment of attention deficit hyperactivity disorder (ADHD), Approved November 2001
Metadate CD; Celltech Pharmaceuticals;
Oral capsules for the treatment of attention deficit hyperactivity disorder, Approved April 2001
Prozac Weekly (fluoxetine HCl); Eli Lilly;
For the treatment of depression, Approved February 2001
Remeron SolTab (mirtazapine); Organon;
Orally disintegrating tablet for the treatment of depression, Approved January 2001
Ziprasidone (ziprasidone hydrochloride); Pfizer;
Oral capsule for the treatment of schizophrenia, Approved February 2001
Drugs Approved in 2000
Concerta; Alza;
For the treatment of Attention Deficit Hyperactivity Disorder, Approved August 2000
Drugs Approved in 1999
Effexor (venlafaxin HCL); Wyeth;
Treatment for generalized anxiety disorder, Approved March 1999
Paxil CR (paroxetine hydrochloride); SmithKline Beecham;
Treatment for depression, Approved March 1999
Sonata; American Home Products;
Treatment fo insomnia, Approved August 1999
Drugs Approved in 1998
Celexa; Forest Laboratories;
Treatment for depression, Approved July 1998
Clomipramine hydrochloride; Mylan Laboratories;
Generic equivalent of Anafranil, Approved April 1998
Cylert; Abbott Laboratories;
Treatment for Attention Deficit Disorder, Approved October 1998
Marplan Tablets; Roche;
Treatment of Depression, Approved August 1998
Naltrexone Hydrochloride Tablets; Barr Laboratories;
Generic equivalent of Revia, Approved May 1998
Prochlorperazine; IVAX;
Generic equivalent of SmithKline Beecham's Compazine, Approved January 1998
Drugs Approved in 1997
Effexor XR (venlafaxin HCI); Wyeth;
Treatment of depression, Approved October 1997
Generic Transdermal Nicotine Patch; Sano;
Generic equivalent of Habitrol, Approved October 1997
LUVOX (fluvoxamine maleate); Solvay Pharmaceuticals, Pharmacia & Upjohn;
Treatment for obsessive compulsive disorder (OCD) in children and adolescents, Approved April 1997
Seroquel (R) (quetiapine fumarate) Tablets; AstraZeneca;
Treatment for schizophrenia, Approved September 1997
Trazadone 150mg; Teva Pharmaceutical;
Generic equivalent of Desyrel 7, Approved May 1997
Zoloft (sertraline HCl); Pfizer;
Treatment for panic disorder, Approved July 1997
Zoloft (sertraline HCl); Pfizer;
Treatment of panic disorder in children ages 6-17, Approved October 1997
Zyban Sustained-Release Tablets; GlaxoSmithKline;
Treatment for smoking cessation, Approved May 1997
Drugs Approved in 1996
Adderall (mixed salts of a single-entity amphetamine); Richwood Pharmaceutical;
Treatment for attention-deficit/hyperactivity disorder, Supplemental NDA Approved February 1996
ARICEPT (donepezil hydrochloride); Eisai;
Treatment for Alzheimer's Disease, Approved December 1996
Depakote (divalproex sodium); Abbott Laboratories;
Treatment for migraine headaches, Approved March 1996
Lithobid (Lithium Carbonate); Solvay Pharmaceuticals;
Treatment for manic depression, Approved January 1996
NicoDerm CQ; SmithKline Beecham, Hoechst Marion Roussel, Alza;
Treatment for smoking cessation, Approved August 1996
Nicorette (nicotine polacrilex); SmithKline Beecham;
Over-the-counter aid in smoking cessation, Approved February 1996
Nicotrol nasal spray; Pharmacia & Upjohn;
Treatment for nicotine addiction, Approved March 1996
Nicotrol transdermal patch; McNeil Consumer Products;
Treatment for smoking cessation, Approved July 1996
Paxil (paroxetine hydrochloride); SmithKline Beecham;
Treatment for panic disorder, Approved May 1996
Redux (dexfenfluramine hydrochloride); Wyeth;
Treatment for obesity, Approved May 1996
Remeron (Mirtazapine); Organon;
Treatment for depression, Approved June 1996
Risperdal Oral Formulation; Janssen Pharmaceuticals;
Treatment for schizophrenia, Approved July 1996
Zyprexa; Eli Lilly;
Treatment of the symptoms of psychotic disorders, Approved September 1996
